LSU Vet Med Advancing Breakthrough Cancer Research
Cancer remains a leading cause of death worldwide, with fewer than 5% of anti-cancer drugs successfully transitioning from laboratory testing to human therapy.
In Louisiana, where the cancer burden is especially severe with over 30,000 new cases diagnosed annually, the LSU School of Veterinary Medicine is stepping up to change those statistics.
Leveraging an $11 million federal grant, the Pre-Clinical Cancer Center of Biomedical Research Excellence (COBRE) at LSU Vet Med is utilizing a "One Health" approach to bridge the gap between animal and human cancer research. Researchers are focusing on innovative strategies, such as developing 3D lab-grown tumors for better drug testing, engineering viruses to destroy cancer cells, creating nature-inspired drugs, and conducting comparative oncology trials in pets.
These efforts aim to secure a National Cancer Institute designation for Louisiana, increasing access to advanced, collaborative treatments.
To learn more about how these world-class teams are transforming the future of oncology, read the full story: https://www.lsu.edu/vetmed/blog/2026/cancer_research.php
Pictured are three leading cancer researchers at LSU Vet Med: Drs. Joseph Francis, Konstantin "Gus" Kousoulas, and Seetharama Jois (l to r).
|